| Conţinutul numărului revistei |
| Articolul precedent |
| Articolul urmator |
 |
 505 1 |
| Ultima descărcare din IBN: 2022-04-13 16:51 |
| Căutarea după subiecte similare conform CZU |
| 616.98:578.834.1]-053.9 (1) |
| Инфекционные заболевания. Инфекционные лихорадки (585) |
| Вирусология (443) |
 SM ISO690:2012POPA, Ana, NEGARĂ, Anatolie, ŞORIC, Gabriela, POPESCU, Ana. Evolutionary particulars of COVID-19 in elderly patients. In: Moldovan Medical Journal, 2020, nr. 6(63), pp. 21-24. ISSN 2537-6373. DOI: https://doi.org/10.5281/zenodo.4028371 |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| Moldovan Medical Journal | ||||||
| Numărul 6(63) / 2020 / ISSN 2537-6373 /ISSNe 2537-6381 | ||||||
|
||||||
| DOI:https://doi.org/10.5281/zenodo.4028371 | ||||||
| CZU: 616.98:578.834.1]-053.9 | ||||||
| Pag. 21-24 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
Background: The new SARS-CoV-2 coronavirus affects a large number of people worldwide, and the elderly are particularly affected because of their vulnerability. Thus, the elderly patients and those with comorbidities have an increased risk of developing a severe disease and show an increased mortality rate. Although they may show mild symptoms of illness and low-grade fever in the early days, they may worsen clinically rapidly, requiring ongoing monitoring. Material and methods: The prospective study was performed on a group of 96 patients (mean age 61.41 ± 3.42 years), with a predominance of men, hospitalized in the Holy Trinity Hospital of Chisinau who met the clinical case definition and were laboratory case-confirmed with COVID-19. Patients were clinically and paraclinically investigated according to the WHO Provisional National Clinical Protocol for COVID-19 infection reporting. The data were statistically processed by the Statistics 10 program. Results: Of the 96 patients with COVID-19, 85 (88.54%) reported at least one had a comorbidity. The prevalence of comorbidities was the following: chronic coronary syndromes (40.1%), hypertension (39.7%), diabetes (16.04%), chronic obstructive pulmonary disease (17.3%), malignancy (13.04%), cerebrovascular disease (10.6%), chronic kidney disease (4.3%) and viral hepatitis B (1.8%). Severe cases of the disease were revealed – 58, medium severity – 38 cases. All critical cases resulting in death (7.29%) showed comorbidities with respiratory symptoms, as well as with the onset of acute respiratory failure. Conclusions: The elderly, male gender and the presence of comorbidities in patients with COVID-19 determine the severe course of the disease and an increased mortality rate. |
||||||
| Cuvinte-cheie COVID-19, elderly, mortality |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Popa, A.N.</dc:creator> <dc:creator>Negară, A.I.</dc:creator> <dc:creator>Şoric, G.N.</dc:creator> <dc:creator>Popescu, A.</dc:creator> <dc:date>2020-12-09</dc:date> <dc:description xml:lang='en'><p>Background: The new SARS-CoV-2 coronavirus affects a large number of people worldwide, and the elderly are particularly affected because of their vulnerability. Thus, the elderly patients and those with comorbidities have an increased risk of developing a severe disease and show an increased mortality rate. Although they may show mild symptoms of illness and low-grade fever in the early days, they may worsen clinically rapidly, requiring ongoing monitoring. Material and methods: The prospective study was performed on a group of 96 patients (mean age 61.41 ± 3.42 years), with a predominance of men, hospitalized in the Holy Trinity Hospital of Chisinau who met the clinical case definition and were laboratory case-confirmed with COVID-19. Patients were clinically and paraclinically investigated according to the WHO Provisional National Clinical Protocol for COVID-19 infection reporting. The data were statistically processed by the Statistics 10 program. Results: Of the 96 patients with COVID-19, 85 (88.54%) reported at least one had a comorbidity. The prevalence of comorbidities was the following: chronic coronary syndromes (40.1%), hypertension (39.7%), diabetes (16.04%), chronic obstructive pulmonary disease (17.3%), malignancy (13.04%), cerebrovascular disease (10.6%), chronic kidney disease (4.3%) and viral hepatitis B (1.8%). Severe cases of the disease were revealed – 58, medium severity – 38 cases. All critical cases resulting in death (7.29%) showed comorbidities with respiratory symptoms, as well as with the onset of acute respiratory failure. Conclusions: The elderly, male gender and the presence of comorbidities in patients with COVID-19 determine the severe course of the disease and an increased mortality rate.</p></dc:description> <dc:identifier>10.5281/zenodo.4028371</dc:identifier> <dc:source>Moldovan Medical Journal 63 (6) 21-24</dc:source> <dc:subject>COVID-19</dc:subject> <dc:subject>elderly</dc:subject> <dc:subject>mortality</dc:subject> <dc:title>Evolutionary particulars of COVID-19 in elderly patients</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>
|
|
|
